Cellromax Science Co., Ltd. (KOSDAQ:471820)
4,110.00
-25.00 (-0.60%)
At close: Aug 11, 2026
-26.61% (1Y)
| Market Cap | 45.38B -27.6% |
| Revenue (ttm) | 20.98B -6.2% |
| Net Income | 3.42B +45.4% |
| EPS | 302.14 +37.6% |
| Shares Out | 11.04M |
| PE Ratio | 13.60 |
| Forward PE | n/a |
| Dividend | 185.00 (4.47%) |
| Ex-Dividend Date | Jun 29, 2026 |
| Volume | 10,276 |
| Open | 4,130.00 |
| Previous Close | 4,135.00 |
| Day's Range | 4,030.00 - 4,230.00 |
| 52-Week Range | 3,410.00 - 7,690.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |